TUBB8P9

Across TCGA pan-cancer cohorts, TUBB8P9 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of TUBB8P9’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where TUBB8P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TUBB8P9 is over-expressed in tumor.

BRCA and LUSC are the cancer types where TUBB8P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TUBB8P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.014	.003	6	view →
LUSC	Female	All	+0.027	.016	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

TUBB8P9–BRCA

Open the BRCA breakdown →